{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:58:04Z","timestamp":1771981084880,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ooooe.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.tripleo.2009.05.047","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T05:43:23Z","timestamp":1251438203000},"page":"318-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Multiple sclerosis: an update for oral health care providers"],"prefix":"10.1016","volume":"108","author":[{"given":"Dena J.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Klasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2009.05.047_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"Alonso","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.58.1.136","article-title":"Prevalence estimates for MS in the United States and evidence of an increasing trend for women","volume":"58","author":"Noonan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000067107","article-title":"The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis","volume":"22","author":"Zivadinov","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s100720170011","article-title":"The prevalence of multiple sclerosis in the world: an update","volume":"22","author":"Rosati","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1016\/j.tripleo.2009.05.047_bib5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.53.8.1711","article-title":"Geographic variation of MS incidence in two prospective studies of US women","volume":"53","author":"Hernan","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.10788","article-title":"Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography","volume":"55","author":"Wallin","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WCO.0b013e32815610c2","article-title":"Multiple sclerosis: the environment and causation","volume":"20","author":"Giovannoni","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng1647","article-title":"A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis","volume":"37","author":"Lincoln","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.tripleo.2009.05.047_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/444547","article-title":"A high-density screen for linkage in multiple sclerosis","volume":"77","author":"Sawcer","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tripleo.2009.05.047_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00001648-200003000-00023","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"11","author":"Ascherio","year":"2000","journal-title":"Epidemiology (Cambridge, Mass)"},{"key":"10.1016\/j.tripleo.2009.05.047_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Archf Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib15","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2009.05.047_bib16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib17","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2009.05.047_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/1352458507086425","article-title":"Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients","volume":"14","author":"Alvarez-Lafuente","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.tripleo.2009.05.047_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/rmv.465","article-title":"Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses","volume":"15","author":"Christensen","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QCO.0b013e3282f88b48","article-title":"Multiple sclerosis: immunopathogenesis and controversies in defining the cause","volume":"21","author":"Holmoy","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.05.047_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0361-9230(03)00095-9","article-title":"Neuropathology of multiple sclerosis-new concepts","volume":"61","author":"Kornek","year":"2003","journal-title":"Brain Res Bull"},{"issue":"1390","key":"10.1016\/j.tripleo.2009.05.047_bib22","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1098\/rstb.1999.0510","article-title":"The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease","volume":"354","author":"Smith","year":"1999","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.tripleo.2009.05.047_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y","article-title":"Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology","volume":"29","author":"Bitsch","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib26","first-page":"1935","article-title":"Diagnosis and management of multiple sclerosis","volume":"70","author":"Calabresi","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.tripleo.2009.05.047_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-8467(00)00125-6","article-title":"Diagnostic criteria for multiple sclerosis","volume":"103","author":"Poser","year":"2001","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.tripleo.2009.05.047_bib28","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4065\/72.12.1184","article-title":"Management of impairment, disability, and handicap due to multiple sclerosis","volume":"72","author":"Stolp-Smith","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tripleo.2009.05.047_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.44.1.28","article-title":"Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota","volume":"44","author":"Rodriguez","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"9268","key":"10.1016\/j.tripleo.2009.05.047_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2009.05.047_bib32","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"The N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.05.047_bib33","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","article-title":"IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event","volume":"66","author":"Kinkel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WCO.0b013e328300c70d","article-title":"Multiple sclerosis: new treatment trials and emerging therapeutic targets","volume":"21","author":"DeAngelis","year":"2008","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.tripleo.2009.05.047_bib36","first-page":"CD005278","article-title":"Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis","author":"Clerico","year":"2008","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.tripleo.2009.05.047_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.50.3.701","article-title":"Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability","volume":"50","author":"Johnson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/135245850000600407","article-title":"Copolymer 1 Multiple Sclerosis Study Group Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years","volume":"6","author":"Johnson","year":"2000","journal-title":"Mult Scler"},{"issue":"9350","key":"10.1016\/j.tripleo.2009.05.047_bib39","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","article-title":"Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial","volume":"360","author":"Hartung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2009.05.047_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.59.6.909","article-title":"Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS","volume":"59","author":"Ghalie","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1474-4422(08)70110-8","article-title":"Getting specific: monoclonal antibodies in multiple sclerosis","volume":"7","author":"Lutterotti","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.05.047_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis","volume":"354","author":"Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.05.047_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-0327(00)00298-6","article-title":"Depression associated with multiple sclerosis","volume":"66","author":"Feinstein","year":"2001","journal-title":"J Affect Disord"},{"issue":"8 Suppl 4","key":"10.1016\/j.tripleo.2009.05.047_bib45","first-page":"S32","article-title":"Symptomatic therapy for underrecognized manifestations of multiple sclerosis","volume":"58","author":"Krupp","year":"2002","journal-title":"Neurology"},{"issue":"Pt 1","key":"10.1016\/j.tripleo.2009.05.047_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/brain\/116.1.117","article-title":"Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up","volume":"116","author":"Runmarker","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.tripleo.2009.05.047_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N Engl J Med"},{"issue":"Pt 3","key":"10.1016\/j.tripleo.2009.05.047_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.tripleo.2009.05.047_bib49","first-page":"600","article-title":"Oral and maxillofacial manifestations of multiple sclerosis","volume":"66","author":"Chemaly","year":"2000","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.tripleo.2009.05.047_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.12968\/denu.2002.29.6.273","article-title":"Multiple sclerosis and oral care","volume":"29","author":"Fiske","year":"2002","journal-title":"Dent Update"},{"key":"10.1016\/j.tripleo.2009.05.047_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpain.2004.11.005","article-title":"Central pain in multiple sclerosis\u2014prevalence and clinical characteristics","volume":"9","author":"Osterberg","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.tripleo.2009.05.047_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0404.1991.tb04937.x","article-title":"Acute and chronic pain syndromes in multiple sclerosis","volume":"84","author":"Stenager","year":"1991","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2009.05.047_bib53","doi-asserted-by":"crossref","first-page":"s150","DOI":"10.1007\/s10072-005-0431-8","article-title":"A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis","volume":"26","author":"De Simone","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.tripleo.2009.05.047_bib54","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.45.7.1294","article-title":"Trigeminal neuralgia in multiple sclerosis","volume":"45","author":"Hooge","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0404.1982.tb03076.x","article-title":"Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features","volume":"65","author":"Jensen","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.tripleo.2009.05.047_bib56","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.49.4.1142","article-title":"Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging","volume":"49","author":"Gass","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.0305-1846.2001.00318.x","article-title":"Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens","volume":"27","author":"Love","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib58","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1212\/WNL.54.6.1368","article-title":"Glossopharyngeal neuralgia and MS","volume":"54","author":"Minagar","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10194-007-0405-8","article-title":"Cluster headache attacks and multiple sclerosis","volume":"8","author":"Gentile","year":"2007","journal-title":"J Headache Pain"},{"key":"10.1016\/j.tripleo.2009.05.047_bib60","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1468-2982.1999.019008732.x","article-title":"Cluster headache-like pain in multiple sclerosis","volume":"19","author":"Leandri","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1468-2982.2004.00725.x","article-title":"Secondary trigeminal autonomic cephalgia associated with multiple sclerosis","volume":"24","author":"Davey","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000008152","article-title":"Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin","volume":"43","author":"Sedano","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.tripleo.2009.05.047_bib64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.tripleo.2009.05.047_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7400","article-title":"Treatments for spasticity and pain in multiple sclerosis: a systematic review","volume":"7","author":"Beard","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.tripleo.2009.05.047_bib66","first-page":"441","article-title":"Oral health status and temporomandibular disorders in multiple sclerosis patients","volume":"29","author":"Kovac","year":"2005","journal-title":"Coll Antropol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib67","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1468-2982.2004.00790.x","article-title":"Prevalence of primary headaches in people with multiple sclerosis","volume":"24","author":"D'Amico","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib68","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-2982.2008.01662.x","article-title":"Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily","volume":"28","author":"Nicoletti","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib69","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00314746","article-title":"Headaches and multiple sclerosis: a clinical study and review of the literature","volume":"237","author":"Rolak","year":"1990","journal-title":"J Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1468-2982.1994.1402139.x","article-title":"Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache","volume":"14","author":"Leone","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1016\/j.tripleo.2009.05.047_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ana.410160214","article-title":"Low T8 antigen density on lymphocytes in active multiple sclerosis","volume":"16","author":"Reder","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1526-4610.1993.hed3308452.x","article-title":"Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area","volume":"33","author":"Haas","year":"1993","journal-title":"Headache"},{"key":"10.1016\/j.tripleo.2009.05.047_bib73","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","article-title":"Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?","volume":"41","author":"Welch","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.tripleo.2009.05.047_bib74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1191\/1352458506ms1298oa","article-title":"Interferon treatment may trigger primary headaches in multiple sclerosis patients","volume":"12","author":"La Mantia","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.tripleo.2009.05.047_bib75","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.59.4.636","article-title":"Interferon beta but not glatiramer acetate therapy aggravates headaches in MS","volume":"59","author":"Pollmann","year":"2002","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2009.05.047_bib76","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1007\/s10072-008-0908-3","article-title":"Primary headache and multiple sclerosis: preliminary results of a prospective study","volume":"29","author":"Villani","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.tripleo.2009.05.047_bib77","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s004150050158","article-title":"Facial palsy in multiple sclerosis","volume":"244","author":"Fukazawa","year":"1997","journal-title":"Journal of neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.35.9.1341","article-title":"Cessation of stuttering with progressive multiple sclerosis","volume":"35","author":"Miller","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.tripleo.2009.05.047_bib79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14219\/jada.archive.2008.0128","article-title":"Neurological outcomes in children with and without amalgam-related mercury exposure: seven years of longitudinal observations in a randomized trial","volume":"139","author":"Lauterbach","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2009.05.047_bib80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.14219\/jada.archive.1999.0168","article-title":"Alzheimer's disease, dental amalgam and mercury","volume":"130","author":"Saxe","year":"1999","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2009.05.047_bib81","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijheh.2005.11.006","article-title":"Mercury amalgam dental fillings: an epidemiologic assessment","volume":"209","author":"Bates","year":"2006","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.tripleo.2009.05.047_bib82","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/ije\/dyh164","article-title":"Health effects of dental amalgam exposure: a retrospective cohort study","volume":"33","author":"Bates","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0300-5712(88)90059-0","article-title":"\u201cMercury poisoning\u201d from dental amalgam\u2014an evaluation of the evidence","volume":"16","author":"Eley","year":"1988","journal-title":"J Dent"},{"key":"10.1016\/j.tripleo.2009.05.047_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.bdj.4800255a","article-title":"Multiple sclerosis, dental caries and fillings: a case-control study","volume":"187","author":"McGrother","year":"1999","journal-title":"Br Dent J"},{"key":"10.1016\/j.tripleo.2009.05.047_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1754-4505.1993.tb01627.x","article-title":"A preliminary study into the dental health status of multiple sclerosis patients","volume":"13","author":"Symons","year":"1993","journal-title":"Spec Care Dentist"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2009.05.047_bib86","first-page":"445","article-title":"Dental status and barriers to care for adults with multiple sclerosis","volume":"46","author":"Griffiths","year":"1996","journal-title":"Int Dent J"},{"key":"10.1016\/j.tripleo.2009.05.047_bib87","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/bdj.2006.125","article-title":"Verifiable CPD paper: factors that influence the dental attendance pattern and maintenance of oral health for people with multiple sclerosis","volume":"202","author":"Baird","year":"2007","journal-title":"Br Dent J"},{"key":"10.1016\/j.tripleo.2009.05.047_bib88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1601-0825.2006.01290.x","article-title":"Therapeutic doses of glucocorticoids: implications for oral medicine","volume":"12","author":"Baid","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2009.05.047_bib89","first-page":"775","article-title":"Immunosuppressants","volume":"36","author":"Chainani-Wu","year":"2008","journal-title":"J Calif Dent Assoc"},{"key":"10.1016\/j.tripleo.2009.05.047_bib90","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bdj.4810660","article-title":"Dental management considerations for the patient with an acquired coagulopathy","volume":"195","author":"Lockhart","year":"2003","journal-title":"Br Dent J"},{"key":"10.1016\/j.tripleo.2009.05.047_bib91","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.tripleo.2009.05.047_bib92","series-title":"Neurologic disorders","author":"Little","year":"2008"},{"key":"10.1016\/j.tripleo.2009.05.047_bib93","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","year":"2006"},{"key":"10.1016\/j.tripleo.2009.05.047_bib94","article-title":"Merck Manual Online Medical Library","year":"2007"},{"key":"10.1016\/j.tripleo.2009.05.047_bib95","article-title":"Drug Information Handbook for Dentistry","year":"2009"},{"key":"10.1016\/j.tripleo.2009.05.047_bib96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.12968\/denu.1999.26.7.288","article-title":"Toothbrush handle adaptation using silicone impression putty","volume":"26","author":"Dickinson","year":"1999","journal-title":"Dent Update"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:13:31Z","timestamp":1761048811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210409003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1079210409003801"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2009.05.047","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis: an update for oral health care providers","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tripleo.2009.05.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}